These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27521616)

  • 1. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
    Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
    Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
    Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
    Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
    Pili B; Reddy LH; Bourgaux C; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    Nanoscale; 2010 Aug; 2(8):1521-6. PubMed ID: 20820745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
    Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
    J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
    Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
    Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
    Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
    Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention.
    Garg NK; Dwivedi P; Campbell C; Tyagi RK
    Eur J Pharm Sci; 2012 Dec; 47(5):1006-14. PubMed ID: 23041219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
    Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
    Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
    Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
    Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
    Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
    Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
    Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane.
    Ambike A; Rosilio V; Stella B; Lepêtre-Mouelhi S; Couvreur P
    Langmuir; 2011 Apr; 27(8):4891-9. PubMed ID: 21413743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.
    Chen EM; Quijano AR; Seo YE; Jackson C; Josowitz AD; Noorbakhsh S; Merlettini A; Sundaram RK; Focarete ML; Jiang Z; Bindra RS; Saltzman WM
    Biomaterials; 2018 Sep; 178():193-203. PubMed ID: 29936153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes.
    Razzazan A; Atyabi F; Kazemi B; Dinarvand R
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():614-25. PubMed ID: 26952465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.